{"content":"<li class=\"n-box-item date-title\" data-end=\"1539057599\" data-start=\"1538971200\" data-txt=\"Monday, December 23, 2019\">Monday, October  8, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3395888\" data-ts=\"1539037958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395888-papa-johnsplus-17-on-report-peltz-is-weighing-takeover-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s +17% on report Peltz is weighing takeover bid</a></h4><ul>   <li>Nelson Peltz and his Trian Fund are considering a <a href=\"https://www.wsj.com/articles/trian-considers-a-takeover-bid-for-papa-johns-1539037437?mod=searchresults&amp;page=1&amp;pos=1\" target=\"_blank\">bid to take over Papa John's International</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>), <i>The Wall Street Journal</i> reports, saying several parties (including companies and private-equity firms) have also expressed an interest in an offer.</li>    <li>Papa John's shares have <font color='green'>jumped 17.2%</font> after hours.</li>    <li>Trian (which has a reputation for working with management of struggling companies) invited former Papa John's CEO John Schnatter to meet with Wendy's (NYSE:<a href='https://seekingalpha.com/symbol/WEN' title='The Wendy&#39;s Company'>WEN</a>) leaders to discuss a potential deal. Peltz is chairman of Wendy's.</li>    <li>In the meeting, Schnatter wanted to know how many seats he'd have on the board of a combined company, according to the <i>WSJ.</i> He owns nearly 30% of Papa John's shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395888\" data-linked=\"Papa John&#39;s +17% on report Peltz is weighing takeover bid\" data-tweet=\"$PZZA $PZZA $WEN - Papa John&#39;s +17% on report Peltz is weighing takeover bid https://seekingalpha.com/news/3395888-papa-johnsplus-17-on-report-peltz-is-weighing-takeover-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3395888-papa-johnsplus-17-on-report-peltz-is-weighing-takeover-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395883\" data-ts=\"1539035977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IQ\" target=\"_blank\">IQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395883-iqiyiplus-3_7-after-jefferies-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IQiyi +3.7% after Jefferies starts at Buy</a></h4><ul>   <li>IQiyi (NASDAQ:<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a>) wrapped the day <font color='green'>up 3.7%</font>, recouping declines from the past few days of trading, after an initiation at Buy by Jefferies.</li>    <li>Analyst Karen Chan set a price target of $33, now implying 25% upside from today's close.</li>    <li>Shares are <font color='green'>up 51.9%</font> over the past six months; they're still 43% below their 52-week high of $46.23 on June 19.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395883\" data-linked=\"IQiyi +3.7% after Jefferies starts at Buy\" data-tweet=\"$IQ - IQiyi +3.7% after Jefferies starts at Buy https://seekingalpha.com/news/3395883-iqiyiplus-3_7-after-jefferies-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3395883-iqiyiplus-3_7-after-jefferies-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395881\" data-ts=\"1539035655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395881-after-hours-gainers-losers-10-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (10/08/2018)</a></h4><ul><li><b>Top Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color='green'>+3.54%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='green'>+2.85%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+2.38%</font>. <a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a> <font color='green'>+1.20%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+0.50%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/AFMD' title='Affimed Therapeutics'>AFMD</a> <font color='red'>-27.21%</font>. <a href='https://seekingalpha.com/symbol/BLKB' title='Blackbaud, Inc.'>BLKB</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='red'>-12.51%</font>. <a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a> <font color='red'>-8.74%</font>. <a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='red'>-1.50%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395881\" data-linked=\"After Hours Gainers / Losers (10/08/2018)\" data-tweet=\"$OPK $OPK $MHLD - After Hours Gainers / Losers (10/08/2018) https://seekingalpha.com/news/3395881-after-hours-gainers-losers-10-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395881-after-hours-gainers-losers-10-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395876\" data-ts=\"1539033121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPG\" target=\"_blank\">PPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395876-ppg-industriesminus-9-after-issuing-downside-q3-earnings-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PPG Industries -9% after issuing downside Q3 earnings, revenue guidance</a></h4><ul>     <li>PPG&nbsp;Industries (NYSE:<a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a>) <font color='red'>-9.7%</font> after-hours <a href=\"https://seekingalpha.com/pr/17293765-ppg-provides-update-third-quarter-2018-financial-results\" target=\"_blank\">issues Q3 guidance</a> for adjusted EPS of $1.41-$1.45 on revenues of $3.8B, below analyst consensus expectations for EPS of $1.59 and revenues of $3.9B.</li>     <li>PPG says it experienced significant raw       material and elevating logistics cost inflation during Q3, including the effects from higher epoxy resin and increasing oil prices, with \"the highest level of cost inflation since the cycle began two years ago.\"</li>     <li>PPG says overall demand in China softened during Q3, and it suffered weaker automotive refinish sales as several U.S. and European customers carried high inventory levels due to lower end-use market demand, and weakening foreign currencies resulted in a $15M decrease in income Y/Y.</li>     <li>For Q4, PPG expects EPS of $1.03-$1.13 with continued raw material cost inflation but at a more modest Y/Y rate than in Q3.</li><li>Peers <a href='https://seekingalpha.com/symbol/SHW' title='The Sherwin-Williams Company'>SHW</a> <font color='red'>-2.6%</font>, <a href='https://seekingalpha.com/symbol/AXTA' title='Axalta Coating Systems'>AXTA</a> <font color='red'>-2.4%</font> after-hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395876\" data-linked=\"PPG Industries -9% after issuing downside Q3 earnings, revenue guidance\" data-tweet=\"$PPG $PPG $SHW - PPG Industries -9% after issuing downside Q3 earnings, revenue guidance https://seekingalpha.com/news/3395876-ppg-industriesminus-9-after-issuing-downside-q3-earnings-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3395876-ppg-industriesminus-9-after-issuing-downside-q3-earnings-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395872\" data-ts=\"1539032341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLKB\" target=\"_blank\">BLKB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395872-blackbauldminus-14_5-on-lowered-fy18-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blackbauld -14.5% on lowered FY18 guidance</a></h4><ul><li>        Blackbauld (NASDAQ:<a href='https://seekingalpha.com/symbol/BLKB' title='Blackbaud, Inc.'>BLKB</a>)<a href=\"https://seekingalpha.com/pr/17293731-blackbaud-updates-2018-full-year-financial-outlook\" target=\"_blank\"> updates</a> its FY18 outlook due to combined reductions in services revenue, transaction-based revenue, and subscription-based recurring revenue.</li><li>               Guidance: Revenue, $844M to $854M (was: $870M to $890M); EPS, $2.46 to $2.52 (was: $2.75 to $2.88); operating margin, 19.3% to 19.6% (was: 20.6% to 21%); FCF, $143M to $147M (was: $165M to $175M).&nbsp;</li><li>               Blackbauld shares were halted ahead of the news but have resumed trading&nbsp;<font color='red'>down 14.5%</font>&nbsp;aftermarket to $77.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3395872\" data-linked=\"Blackbauld -14.5% on lowered FY18 guidance\" data-tweet=\"$BLKB - Blackbauld -14.5% on lowered FY18 guidance https://seekingalpha.com/news/3395872-blackbauldminus-14_5-on-lowered-fy18-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3395872-blackbauldminus-14_5-on-lowered-fy18-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395866\" data-ts=\"1539031131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFMD\" target=\"_blank\">AFMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395866-affimed-suspends-clinical-studies-of-blood-cancer-candidate-afm11-after-adverse-events\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Affimed suspends clinical studies of blood cancer candidate AFM11 after adverse events</a></h4><ul><li>Affimed N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/AFMD' title='Affimed Therapeutics'>AFMD</a>) has placed its AFM11 program on <a href=\"https://seekingalpha.com/pr/17293730-affimed-places-afm11-cd19-cd3-targeting-t-cell-engager-phase-1-program-clinical-hold\" target=\"_blank\">clinical hold</a> following three serious adverse events (SAEs), one death in a Phase 1 ALL study and two life-threatening events in a Phase 1 NHL study.</li><li>The SAEs occurred in patients receiving the highest dose in each of the respective studies. 33 total patients have been treated to date.</li><li>The company is working with global health authorities to investigate the SAEs and determine the next steps.</li><li>AFM11 is a CD19/CD3-targeting T cell engager, a tandem antibody the company calls <a href=\"http://www.affimed.com/\" target=\"_blank\">TandAbs</a>, that establishes a bridge between certain immune cells that boosts their ability to kill cancer cells.</li><li>Shares, currently halted, will resume trading at 4:45 pm ET.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>29%</font>&nbsp;on resumption of trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395866\" data-linked=\"Affimed suspends clinical studies of blood cancer candidate AFM11 after adverse events\" data-tweet=\"$AFMD - Affimed suspends clinical studies of blood cancer candidate AFM11 after adverse events https://seekingalpha.com/news/3395866-affimed-suspends-clinical-studies-of-blood-cancer-candidate-afm11-after-adverse-events?source=tweet\" data-url=\"https://seekingalpha.com/news/3395866-affimed-suspends-clinical-studies-of-blood-cancer-candidate-afm11-after-adverse-events\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395862\" data-ts=\"1539030516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EW\" target=\"_blank\">EW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395862-edwards-lifesciences-launches-u-s-study-of-centera-valve-in-severe-aortic-stenosis-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edwards Lifesciences launches U.S. study of Centera valve in severe aortic stenosis; shares up 1% after hours</a></h4><ul><li>Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a>) perks up&nbsp;<font color='green'>1%</font>&nbsp;after hours on the heels of the start of a <a href=\"https://seekingalpha.com/pr/17293717-edwards-announces-start-u-s-study-self-expanding-transcatheter-heart-valve\" target=\"_blank\">U.S. pivotal study</a> evaluating its self-expanding CENTERA trancatheter valve for the treatment of severe symptomatic aortic stenosis in patients at immediate risk of open-heart surgery.</li><li>The primary endpoint of the 1,000-subject trial is a composite of all-cause death and/or stroke at year 1.</li><li>The European Commission approved CENTERA in February.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395862\" data-linked=\"Edwards Lifesciences launches U.S. study of Centera valve in severe aortic stenosis; shares up 1% after hours\" data-tweet=\"$EW - Edwards Lifesciences launches U.S. study of Centera valve in severe aortic stenosis; shares up 1% after hours https://seekingalpha.com/news/3395862-edwards-lifesciences-launches-u-s-study-of-centera-valve-in-severe-aortic-stenosis-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3395862-edwards-lifesciences-launches-u-s-study-of-centera-valve-in-severe-aortic-stenosis-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395860\" data-ts=\"1539030428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAT\" target=\"_blank\">USAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395860-usa-technologies-receives-nasdaq-noncompliance-letter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Technologies receives Nasdaq noncompliance letter</a></h4><ul><li>        USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) <a href=\"https://seekingalpha.com/pr/17293722-usa-technologies-inc-announces-receipt-nasdaq-notice\" target=\"_blank\">announces</a> receiving a notice from the Nasdaq notifying the company of noncompliance due to its failure to file a timely financial report.</li><li>               USA Tech has until November 1 to submit a plan to regain compliance. If Nasdaq accepts that plan, it can grant 180 days for the company to regain compliance. That date would push the deadline until March 12.&nbsp;</li><li>               USAT shares closed today&nbsp;<font color='red'>down 9.7%</font>&nbsp;to $6.40.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3395860\" data-linked=\"USA Technologies receives Nasdaq noncompliance letter\" data-tweet=\"$USAT - USA Technologies receives Nasdaq noncompliance letter https://seekingalpha.com/news/3395860-usa-technologies-receives-nasdaq-noncompliance-letter?source=tweet\" data-url=\"https://seekingalpha.com/news/3395860-usa-technologies-receives-nasdaq-noncompliance-letter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395855\" data-ts=\"1539029940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHT\" target=\"_blank\">EGHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395855-8x8-appoints-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">8x8 appoints new CFO</a></h4><ul><li>        8x8 (NASDAQ:<a href='https://seekingalpha.com/symbol/EGHT' title='8X8 Inc'>EGHT</a>) <a href=\"https://seekingalpha.com/pr/17293689-8x8-inc-announces-executive-leadership-appointments\" target=\"_blank\">appoints</a> Steven Gatoff as CFO. Current CFO Mary Ellen Genovese will remain on through the Q2 filing and host the earning&rsquo;s call on October 29.</li><li>                  Gatoff work history includes Elementum, Rapid7, and iPass.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3395855\" data-linked=\"8x8 appoints new CFO\" data-tweet=\"$EGHT - 8x8 appoints new CFO https://seekingalpha.com/news/3395855-8x8-appoints-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3395855-8x8-appoints-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395850\" data-ts=\"1539028845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMT\" target=\"_blank\">AMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395850-reits-climb-broader-market-slumps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REITs climb as the broader market slumps</a></h4><ul><li>Real estate investment trusts make significant gains as the broader stock market slumps, dragged down by tech stocks.</li><li>Real Estate Sector SPDR ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLRE' title='Real Estate Select Sector SPDR ETF'>XLRE</a>)&nbsp;<font color='green'>rises 1.5%</font>,&nbsp; after -4% return in the past month. Included in the ETF are: American Tower (<a href='https://seekingalpha.com/symbol/AMT' title='American Tower Corporation'>AMT</a> <font color='green'>+0.7%</font>), Crown Castle International (<a href='https://seekingalpha.com/symbol/CCI' title='Crown Castle International Corp.'>CCI</a> <font color='green'>+1.4%</font>), Simon Property Group (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+2.1%</font>), and Prologis (<a href='https://seekingalpha.com/symbol/PLD' title='Prologis'>PLD</a> <font color='green'>+1.5%</font>).</li><li>SuperDividend REIT ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/SRET' title='Global X SuperDividend REIT ETF'>SRET</a>) is&nbsp;<font color='green'>up 1.2%</font>&nbsp;and includes Medical Properties Trust (<a href='https://seekingalpha.com/symbol/MPW' title='Medical Properties Trust, Inc.'>MPW</a> <font color='green'>+1.8%</font>), Global Net Lease (<a href='https://seekingalpha.com/symbol/GNL' title='Global Net Lease, Inc.'>GNL</a> <font color='green'>+2.8%</font>), Independence Realty Trust (<a href='https://seekingalpha.com/symbol/IRT' title='Independence Realty Trust'>IRT</a> <font color='green'>+3%</font>), and Park Hotels &amp; Resorts (<a href='https://seekingalpha.com/symbol/PK' title='Park Hotels & Resorts Inc.'>PK</a> <font color='green'>+1.7%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395789-homebuilders-decline-take-breather\" target=\"_blank\">Homebuilders' decline take a breather</a> (Oct. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395850\" data-linked=\"REITs climb as the broader market slumps\" data-tweet=\"$AMT $XLRE $AMT - REITs climb as the broader market slumps https://seekingalpha.com/news/3395850-reits-climb-broader-market-slumps?source=tweet\" data-url=\"https://seekingalpha.com/news/3395850-reits-climb-broader-market-slumps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395851\" data-ts=\"1539028763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COG\" target=\"_blank\">COG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395851-newly-opened-atlantic-sunrise-pipeline-opens-door-for-cabot-oil-gas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newly opened Atlantic Sunrise pipeline opens door for Cabot Oil &amp; Gas</a></h4><ul>     <li>Cabot Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+1.8%</font>) is higher following a <a href=\"https://www.barrons.com/articles/new-pipeline-opens-a-door-for-this-natural-gas-producer-1538773261\" target=\"_blank\">weekend <em>Barron's</em> article</a> that highlighted  the newly opened Atlantic Sunrise natural gas pipeline linking the Marcellus region to east coast markets.</li>     <li>COG has about half the capacity on the pipeline, which is expected to carry 1.7B cf/day of gas, or ~2% of U.S. production, and connect with a larger network of pipelines that carry gas along the eastern U.S., alleviating some of the bottlenecks that have held back Marcellus gas production.</li>     <li>Macquarie analyst Paul Grigel thinks the Atlantic Sunrise opening should prove positive for COG shares by helping &ldquo;remove the near-term overhang of future delays\" and help the company &ldquo;grow production and receive more diversified pricing while generally helping Appalachia takeaways and differentials.\"</li><li><a href=\"https://seekingalpha.com/news/3395194-williams-wins-ferc-approval-place-atlantic-sunrise-pipeline-full-service\" target=\"_blank\">Earlier</a>: Williams wins FERC approve to place Atlantic Sunrise pipeline in full service (Oct. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395851\" data-linked=\"Newly opened Atlantic Sunrise pipeline opens door for Cabot Oil &amp; Gas\" data-tweet=\"$COG - Newly opened Atlantic Sunrise pipeline opens door for Cabot Oil &amp; Gas https://seekingalpha.com/news/3395851-newly-opened-atlantic-sunrise-pipeline-opens-door-for-cabot-oil-gas?source=tweet\" data-url=\"https://seekingalpha.com/news/3395851-newly-opened-atlantic-sunrise-pipeline-opens-door-for-cabot-oil-gas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395841\" data-ts=\"1539027820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395841-fda-nod-for-akceas-intersen-fails-to-lift-shares-down-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA nod for Akcea&#39;s intersen fails to lift shares, down 16%</a></h4><ul><li>Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-8.5%</font>) and affiliate Akcea Therapeutics (<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a> <font color='red'>-15.7%</font>) slump on increased volume following FDA approval for TEGSEDI (inotersen) for hATTR. Normally, a bullish event but investors appear concerned about its ability to compete with Alnylam Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-3.6%</font>) <a href=\"http://www.alnylam.com/wp-content/uploads/2018/08/ONPATTRO-Prescribing-Information.pdf\" target=\"_blank\">ONPATTRO </a>(patisiran).</li><li>The culprit appears to be TEGSEDI's <a href=\"http://akceatx.com/wp-content/uploads/US-TEG-1800090-_Tegsedi-PI_10-2018.pdf\" target=\"_blank\">black box warning</a> about potential serious side effects, specifically, thrombocytopenia (low blood platelets) and glomerulonephritis (acute kidney inflammation), warnings ONPATTRO does not have and does not require the pre-treatment testing and patient monitoring needed with TEGSEDI.</li><li>A plus for TEGSEDI is once-weekly self-administration versus ONPATTRO's intravenous infusion every three weeks.</li><li>On the pricing front, both drugs are listed at $450K per year, but Alnylam <a href=\"https://endpts.com/ionis-and-akcea-get-their-shot-at-competing-with-alnylam-for-a-rare-disease-group-but-its-not-expected-to-be-pretty/\" target=\"_blank\">expects discounting</a> to lower the net price of ONPATTRO to ~$345K. Akcea has yet to project where it expects TEGSEDI's net price to settle out.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395613-fda-oks-akceas-inotersen-hattr\" target=\"_blank\">FDA OKs Akcea's inotersen for hATTR</a> (Oct. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395841\" data-linked=\"FDA nod for Akcea&#39;s intersen fails to lift shares, down 16%\" data-tweet=\"$IONS $IONS $AKCA - FDA nod for Akcea&#39;s intersen fails to lift shares, down 16% https://seekingalpha.com/news/3395841-fda-nod-for-akceas-intersen-fails-to-lift-shares-down-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3395841-fda-nod-for-akceas-intersen-fails-to-lift-shares-down-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395842\" data-ts=\"1539027110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395842-sonys-venom-sets-october-record-80m-opening\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony&#39;s &#39;Venom&#39; sets October record with $80M opening</a></h4><ul>   <li>Antihero film <i>Venom</i> delivered the best-ever October weekend opening for Sony (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-0.3%</font>), edging a strong opening for the latest Lady Gaga-powered iteration of <i>A Star is Born</i> (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+0.3%</font>).</li>    <li>Sony's film drew just over $80M, easily eclipsing the $55.7M drawn by <i>Gravity</i> in 2013, despite lackluster critical reception.</li>    <li>It also set a global record for October, cresting $205M worldwide.</li>    <li><i>A Star is Born</i> was no slouch with $41.3M, topping a set of smaller returnees including <i>Smallfoot</i> (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>, $14.9M), <i>Night School</i> (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+1.7%</font>, $12.3M) and <i>The House With a Clock in its Walls</i> (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>, $7.3M).</li>    <li>Among slightly longer runners: <i>The Nun</i> (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) reached $113.4M domestic gross in its fifth week, and <i>Crazy Rich Asians</i> (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) reached $169.1M in its eight week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395842\" data-linked=\"Sony&#39;s &#39;Venom&#39; sets October record with $80M opening\" data-tweet=\"$T $T $CMCSA - Sony&#39;s &#39;Venom&#39; sets October record with $80M opening https://seekingalpha.com/news/3395842-sonys-venom-sets-october-record-80m-opening?source=tweet\" data-url=\"https://seekingalpha.com/news/3395842-sonys-venom-sets-october-record-80m-opening\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395840\" data-ts=\"1539025403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395840-wsj-d-e-shaw-joins-continental-grain-in-pushing-for-change-bunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: D.E. Shaw joins Continental Grain in pushing for change at Bunge</a></h4><ul>     <li>The D.E. Shaw hedge fund has raised its stake in Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+2.6%</font>) and is working with Continental Grain Co. in <a href=\"https://www.wsj.com/articles/d-e-shaw-joins-continental-grain-in-pushing-for-change-at-bunge-1539024275\" target=\"_blank\">pushing BG to make operational improvements</a> or add board members, <em>WSJ</em> reports.</li>     <li>The firms, which together own less than 5%, have been speaking to BG&rsquo;s management in recent weeks, trying to convince the company to make its operations more focused, improve margins and replace board members but are not pushing for a sale of the company, according to the report.</li>     <li><em>WSJ</em> <a href=\"https://seekingalpha.com/news/3336428-bunge-plus-4-percent-investors-reportedly-pressure-consider-sale\" target=\"_blank\">reported in March</a> that Continental Grain was preparing to push BG to consider strategic options.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395840\" data-linked=\"WSJ: D.E. Shaw joins Continental Grain in pushing for change at Bunge\" data-tweet=\"$BG - WSJ: D.E. Shaw joins Continental Grain in pushing for change at Bunge https://seekingalpha.com/news/3395840-wsj-d-e-shaw-joins-continental-grain-in-pushing-for-change-bunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3395840-wsj-d-e-shaw-joins-continental-grain-in-pushing-for-change-bunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395837\" data-ts=\"1539025225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395837-technology-top-5-gainers-losers-of-3_00-pm-10-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM (10/08/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VIV' title='Telefonica Brasil, S.A'>VIV</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/TSU' title='TIM Participações S.A.'>TSU</a> <font color='green'>+5%</font>.</li><li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings'>SGH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395837\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM (10/08/2018)\" data-tweet=\"$FNJN $FNJN $EMKR - Technology - Top 5 Gainers / Losers as of 3.00 PM (10/08/2018) https://seekingalpha.com/news/3395837-technology-top-5-gainers-losers-of-3_00-pm-10-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395837-technology-top-5-gainers-losers-of-3_00-pm-10-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395838\" data-ts=\"1539025189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395838-small-cap-underperformance-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small cap underperformance continues</a></h4><ul><li>The Dow and S&amp;P 500 have reversed into the green, but the Russell 2000 remains modestly lower for the session.</li><li>What gives with the small caps?</li><li>At summer's end, the Russell 2000 was nicely ahead of the DJIA and S&amp;P year-to-date, but&nbsp;<font color='red'>has dipped 6.5%</font>&nbsp;in the five weeks since, while the Dow has&nbsp;<font color='green'>added 2%</font>&nbsp;and the S&amp;P has stayed flat.</li><li>At the moment, the DJIA and S&amp;P are both up about 7% YTD, topping the Russell 2000 by roughly 200 basis points.</li><li>At least someone is spotting value: Bloomberg reports Leonard Green as hoping to raise as much as $2B for its initial small-cap fund.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/IWM' title='iShares Russell 2000 ETF'>IWM</a>, <a href='https://seekingalpha.com/symbol/TZA' title='Direxion Daily Small Cap Bear 3x Shares ETF'>TZA</a>, <a href='https://seekingalpha.com/symbol/TNA' title='Direxion Daily Small Cap Bull 3x Shares ETF'>TNA</a>, <a href='https://seekingalpha.com/symbol/IJR' title='iShares Core S&P Small-Cap ETF'>IJR</a>, <a href='https://seekingalpha.com/symbol/VB' title='Vanguard Small Cap ETF'>VB</a>, <a href='https://seekingalpha.com/symbol/SCHA' title='Schwab U.S. Small-Cap ETF'>SCHA</a>, <a href='https://seekingalpha.com/symbol/UWM' title='ProShares Ultra Russell 2000 ETF'>UWM</a>, <a href='https://seekingalpha.com/symbol/SLY' title='SPDR S&P 600 Small Cap ETF'>SLY</a>, <a href='https://seekingalpha.com/symbol/TWM' title='ProShares UltraShort Russell 2000 ETF'>TWM</a>, <a href='https://seekingalpha.com/symbol/URTY' title='ProShares UltraPro Russell 2000 ETF'>URTY</a>, <a href='https://seekingalpha.com/symbol/RWJ' title='Oppenheimer Small Cap Revenue ETF'>RWJ</a>, <a href='https://seekingalpha.com/symbol/RWM' title='ProShares Short Russell2000 ETF'>RWM</a>, <a href='https://seekingalpha.com/symbol/SRTY' title='ProShares UltraPro Short Russell 2000 ETF'>SRTY</a>, <a href='https://seekingalpha.com/symbol/VIOO' title='Vanguard S&P Small-Cap 600 ETF'>VIOO</a>, <a href='https://seekingalpha.com/symbol/VTWO' title='Vanguard Russell 2000 ETF'>VTWO</a>, <a href='https://seekingalpha.com/symbol/SAA' title='ProShares Ultra SmallCap600 ETF'>SAA</a>, <a href='https://seekingalpha.com/symbol/SBB' title='ProShares Short SmallCap600 ETF'>SBB</a>, <a href='https://seekingalpha.com/symbol/SPSM' title='SPDR Portfolio Small Cap ETF'>SPSM</a>, <a href='https://seekingalpha.com/symbol/SDD' title='ProShares UltraShort SmallCap600 ETF'>SDD</a>, <a href='https://seekingalpha.com/symbol/FYX' title='First Trust Small Cap Core AlphaDEX ETF'>FYX</a>, <a href='https://seekingalpha.com/symbol/RSCO' title='SPDR Russell Small Cap Completeness ETF'>RSCO</a>, <a href='https://seekingalpha.com/symbol/JKJ' title='iShares Morningstar Small-Cap ETF'>JKJ</a>, <a href='https://seekingalpha.com/symbol/SMLF' title='iShares Edge MSCI Multifactor USA Small-Cap ETF'>SMLF</a>, <a href='https://seekingalpha.com/symbol/EWSC' title='Invesco S&P SmallCap 600 Equal Weight ETF'>EWSC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3395838\" data-linked=\"Small cap underperformance continues\" data-tweet=\"$IWM $TZA $TNA - Small cap underperformance continues https://seekingalpha.com/news/3395838-small-cap-underperformance-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3395838-small-cap-underperformance-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395836\" data-ts=\"1539025017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPG\" target=\"_blank\">SPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395836-simon-property-to-build-nhl-seattle-team-headquarters-training-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Simon Property to build NHL Seattle team headquarters, training center</a></h4><ul><li>Simon Property Group (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+2.3%</font>)&nbsp;announces<a href=\"https://seekingalpha.com/pr/17293604-nhl-seattle-simon-join-build-team-headquarters-training-center-northgate\" target=\"_blank\">&nbsp;an agreement</a>&nbsp;with NHL Seattle to build team headquarters and a training center at Northgate.</li><li>The NHL Seattle facility is part of the larger redevelopment project to turn the mall into a transit-oriented mixed-use center.</li><li>The NHL part of the complex will include three full NHL-size ice sheets and a practice/training center. NHL Seattle says it's closing in on obtaining an NHL franchise for the city.</li><li>Simon envisions Northgate having more than 500,000 square feet of retail and commercial space, about 800,000 square feet of class A office space, and up to 1,200 residential units, and space for hospitality uses. A light rail station is expected to b added in the summer of 2021.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3375313-simon-property-q2-beats-boosts-forecast-dividend\" target=\"_blank\">Simon Property Q2 beats; boosts forecast and dividend</a> (July 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395836\" data-linked=\"Simon Property to build NHL Seattle team headquarters, training center\" data-tweet=\"$SPG - Simon Property to build NHL Seattle team headquarters, training center https://seekingalpha.com/news/3395836-simon-property-to-build-nhl-seattle-team-headquarters-training-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3395836-simon-property-to-build-nhl-seattle-team-headquarters-training-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395834\" data-ts=\"1539024701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEIX\" target=\"_blank\">PEIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395834-energy-materials-top-5-gainers-losers-of-2-50-pm-10-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials  - Top 5 Gainers / Losers as of 2:50 PM (10/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Ltd'>ACH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395834\" data-linked=\"Energy/Materials  - Top 5 Gainers / Losers as of 2:50 PM (10/08/2018)\" data-tweet=\"$PEIX $PEIX $IGC - Energy/Materials - Top 5 Gainers / Losers as of 2:50 PM (10/08/2018) https://seekingalpha.com/news/3395834-energy-materials-top-5-gainers-losers-of-2-50-pm-10-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395834-energy-materials-top-5-gainers-losers-of-2-50-pm-10-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395821\" data-ts=\"1539019639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395821-linkedin-acquires-employee-engagement-firm-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn acquires employee engagement firm (update)</a></h4><ul><li>Microsoft&rsquo;s (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a> <font color='red'>-1.9%</font>) LinkedIn <a href=\"https://techcrunch.com/2018/10/08/linkedin-acquires-employee-engagement-and-retention-platform-glint/\" target=\"_blank\">acquires</a> employee engagement firm Glint for undisclosed terms.</li><li>The Glint team will join LinkedIn and continue as its own entity under the existing executive team.</li><li>Glint uses machine learning, natural language processing, and predictive analytics to analyze employee surveys, measure different aspects of workplace culture, and recommend changes that an employer could make.</li><li>Glint has raised nearly $80M in private funding and was valued at about $220M as of its last round.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395691-reuters-eu-will-approve-microsofts-github-buy\" target=\"_blank\">Reuters: EU will approve Microsoft's GitHub buy</a> (Oct. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395763-microsoft-unveils-game-streaming-service-2019-public-trials\" target=\"_blank\">Microsoft unveils game streaming service with 2019 public trials</a> (Oct. 8)</li><li>Update: CNBC sources are <a href=\"https://www.cnbc.com/2018/10/08/microsoft-spent-over-400-million-to-show-its-committed-to-linkedin.html\" target=\"_blank\">putting the deal</a> between $400M and $500M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395821\" data-linked=\"LinkedIn acquires employee engagement firm (update)\" data-tweet=\"$MSFT - LinkedIn acquires employee engagement firm (update) https://seekingalpha.com/news/3395821-linkedin-acquires-employee-engagement-firm-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3395821-linkedin-acquires-employee-engagement-firm-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395817\" data-ts=\"1539018430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPG\" target=\"_blank\">LPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395817-dorian-lpg-responds-to-bws-pulled-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dorian LPG responds to BW&#39;s pulled offer</a></h4><ul> <li>Dorian (<a href='https://seekingalpha.com/symbol/LPG' title='Dorian LPG Ltd.'>LPG</a> <font color='red'>-5.4%</font>) responds to BW's withdrawal of its proposal to acquire the company in a letter sent to the board.</li>                  <li>The company says the BW offer undervalued it on a relative net asset value basis as the calculations overvalued \"older, less fuel-efficient\" vessels and undervalued Dorian's \"young, fuel-efficient\" vessels.</li><li>Doiran says it asked several times if BW could improve its proposal and left the door open to further discussion.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17293492-dorian-lpg-responds-bws-withdrawal-proposal-acquire-dorian\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3395817\" data-linked=\"Dorian LPG responds to BW&#39;s pulled offer\" data-tweet=\"$LPG - Dorian LPG responds to BW&#39;s pulled offer https://seekingalpha.com/news/3395817-dorian-lpg-responds-to-bws-pulled-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3395817-dorian-lpg-responds-to-bws-pulled-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395812\" data-ts=\"1539017791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGSH\" target=\"_blank\">HGSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395812-financials-top-5-gainers-losers-of-12-55-pm-10-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 12:55 PM (10/08/2018)</a></h4><ul><li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BBDO' title='Banco Bradesco S.A.'>BBDO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a> <font color='green'>+8%</font>.</li><li><b>Losers: </b><a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FPI' title='Farmland Partners Inc'>FPI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395812\" data-linked=\"Financials - Top 5 Gainers / Losers as of 12:55 PM (10/08/2018)\" data-tweet=\"$HGSH $HGSH $BSBR - Financials - Top 5 Gainers / Losers as of 12:55 PM (10/08/2018) https://seekingalpha.com/news/3395812-financials-top-5-gainers-losers-of-12-55-pm-10-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395812-financials-top-5-gainers-losers-of-12-55-pm-10-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395808\" data-ts=\"1539017234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395808-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='green'>+32%</font>. CIG-C <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Aéreas Inteligentes S.A.'>GOL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/AZUL' title='Azul'>AZUL</a> <font color='green'>+15%</font>. EBR-B <font color='green'>+14%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a>&nbsp;<font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>&nbsp;<font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation Class A'>DOGZ</a>&nbsp;<font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a>&nbsp;<font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>&nbsp;<font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/NVLN' title='Novelion Therapeutics, Inc.'>NVLN</a>&nbsp;<font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>&nbsp;<font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>&nbsp;<font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HYRE' title='HyreCar'>HYRE</a>&nbsp;<font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a>&nbsp;<font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395808\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PYX $PYX $AMTX - Midday Gainers / Losers https://seekingalpha.com/news/3395808-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3395808-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395807\" data-ts=\"1539016610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395807-gold-heads-for-worst-one-day-drop-since-august\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold heads for worst one-day drop since August</a></h4><ul>     <li>Gold is on track for its <a href=\"https://www.ft.com/content/3a5e8016-cb0c-11e8-b276-b9069bde0956\" target=\"_blank\">biggest one-day price decline since mid-August</a> after the U.S. dollar rose to approach its highest level in nearly two months; Comex gold currently <font color='red'>-1.3%</font> to $1,189.70/oz., and silver <font color='red'>-2.3%</font> to $14.31/oz.</li>     <li>The greenback jumped last week after a series of upbeat U.S. economic data that should keep the Federal Reserve on track to raise interest rates again before year-end.</li>     <li>&ldquo;Gold&rsquo;s weakness is not just due to the stronger dollar, but the rising yields, too,&rdquo; says Forex.com technical analyst Fawad Razaqzada. &ldquo;Together, these factors are proving to be a toxic mix for the non-interest-bearing and buck-denominated commodity... Unless at least one of these influences are not put right, <a href=\"https://www.marketwatch.com/story/gold-resumes-slide-with-attention-on-rising-rates-dollar-strength-2018-10-08\" target=\"_blank\">gold will struggle to sustain any rally</a>.\"</li><li>Adding to the jittery mood, China&rsquo;s central bank yesterday lowered the  level of cash commercial central banks need to keep in reserve.</li><li>Among precious metals miners: ABX <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-0.9%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='red'>-1.7%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='red'>-1%</font>, <a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color='red'>-1.5%</font>, <a href='https://seekingalpha.com/symbol/FNV' title='Franco-Nevada Corporation'>FNV</a> <font color='red'>-1%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='red'>-0.8%</font>, <a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a> <font color='red'>-0.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares UltraShort Silver ETF'>ZSL</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/DBS' title='Invesco DB Silver ETF'>DBS</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust ETF'>BAR</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/USV' title='UBS ETRACS CMCI Silver Total Return ETN'>USV</a>, <a href='https://seekingalpha.com/symbol/SHNY' title='Direxion Daily Silver Miners Index Bull 2x Shares ETF'>SHNY</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/MELT' title='Direxion Daily Gold Miners Index Bear 1x Shares ETF'>MELT</a>, <a href='https://seekingalpha.com/symbol/DULL' title='Direxion Daily Silver Miners Index Bear 2x Shares ETF'>DULL</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Shares SPDR Gold Minishares Trust ETF'>GLDM</a>, <a href='https://seekingalpha.com/symbol/IAUF' title='iShares Gold Strategy ETF'>IAUF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3395807\" data-linked=\"Gold heads for worst one-day drop since August\" data-tweet=\"$GOLD $GOLD $NEM - Gold heads for worst one-day drop since August https://seekingalpha.com/news/3395807-gold-heads-for-worst-one-day-drop-since-august?source=tweet\" data-url=\"https://seekingalpha.com/news/3395807-gold-heads-for-worst-one-day-drop-since-august\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395801\" data-ts=\"1539014936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVRO\" target=\"_blank\">NVRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395801-medical-device-makers-in-red\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical device makers in the red</a></h4><ul><li>The market's down day notwithstanding, medical device makers are under pressure. The Nasdaq Composite has sold off over&nbsp;<font color='red'>5%</font>&nbsp;since last week. The iShares US Medical Devices ETF (<a href='https://seekingalpha.com/symbol/IHI' title='iShares U.S. Medical Devices ETF'>IHI</a> <font color='red'>-1.8%</font>) has sold off the same amount since touching $228.90 on October 1.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color='red'>-5.4%</font>)(<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/WMGI' title='Wright Medical Group, Inc.'>WMGI</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a>)(<a href='https://seekingalpha.com/symbol/SNN' title='Smith & Nephew plc'>SNN</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a> <font color='red'>-2.1%</font>)(<a href='https://seekingalpha.com/symbol/OSUR' title='OraSure Technologies, Inc.'>OSUR</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-7.6%</font>)(<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color='red'>-2.6%</font>)(<a href='https://seekingalpha.com/symbol/CNMD' title='CONMED Corporation'>CNMD</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/BIO' title='Bio-Rad Laboratories, Inc.'>BIO</a> <font color='red'>-1.4%</font>)(<a href='https://seekingalpha.com/symbol/BAX' title='Baxter International Inc'>BAX</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/ANGO' title='AngioDynamics, Inc.'>ANGO</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a> <font color='red'>-1.4%</font>)(<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a> <font color='red'>-2.1%</font>)(<a href='https://seekingalpha.com/symbol/XHE' title='SPDR S&P Health Care Equipment ETF'>XHE</a> <font color='red'>-2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395801\" data-linked=\"Medical device makers in the red\" data-tweet=\"$NVRO $IHI $NVRO - Medical device makers in the red https://seekingalpha.com/news/3395801-medical-device-makers-in-red?source=tweet\" data-url=\"https://seekingalpha.com/news/3395801-medical-device-makers-in-red\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395799\" data-ts=\"1539014585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395799-comtech-adds-2_3m-in-funding-new-1_9m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech adds $2.3M in funding, new $1.9M deal</a></h4><ul>   <li>In its most recent contract updates, Comtech Telecommunications (<a href=\"http://seekingalpha.com/symbol/CMTL\" target=\"_blank\">CMTL</a> <font color='red'>-2.7%</font>) says it's gotten $2.3M in funding from the State of Maryland and sealed a new $1.9M deal.</li>    <li>In the <a href=\"https://seekingalpha.com/pr/17293254-comtech-telecommunications-corp-receives-2_3-million-funding-support-state-maryland\" target=\"_blank\">Maryland deal</a>, Comtech's Command and Control Technologies group got extra funding for option year one on an existing deal providing the state's Department of Human Services with technical operations support. That makes $6.7M in funded orders so far against an $11.3M ceiling.</li>    <li>Meanwhile, its Enterprise Technologies group on the commercial side has a new multiyear order for $1.9M from a <a href=\"https://seekingalpha.com/pr/17293250-comtech-telecommunications-corp-announces-new-contract-worth-1_9-million-top-u-s-telecom\" target=\"_blank\">top U.S. telecom service provider</a> to offer hosted data assistance services, designed to enable value-added location-based service.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395799\" data-linked=\"Comtech adds $2.3M in funding, new $1.9M deal\" data-tweet=\"$CMTL - Comtech adds $2.3M in funding, new $1.9M deal https://seekingalpha.com/news/3395799-comtech-adds-2_3m-in-funding-new-1_9m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3395799-comtech-adds-2_3m-in-funding-new-1_9m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395797\" data-ts=\"1539014507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395797-consumer-top-gainers-losers-of-12-00-pm-10-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (10/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation Class A'>DOGZ</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395797\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (10/08/2018)\" data-tweet=\"$PYX $PYX $TPB - Consumer - Top Gainers / Losers as of 12:00 PM (10/08/2018) https://seekingalpha.com/news/3395797-consumer-top-gainers-losers-of-12-00-pm-10-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395797-consumer-top-gainers-losers-of-12-00-pm-10-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395796\" data-ts=\"1539014171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395796-stocks-continue-to-slump-nasdaq-down-another-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks continue to slump, Nasdaq down another 1.5%</a></h4><ul><li>Once again, tech is leading the decline, with the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>)&nbsp;<font color='red'>off 1.5%</font>&nbsp;vs. the S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>)&nbsp;<font color='red'>down 0.75%</font>, and the Dow (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>)&nbsp;<font color='red'>lower by 0.8%</font>. The Russell 2000 (NYSEARCA:<a href='https://seekingalpha.com/symbol/IWM' title='iShares Russell 2000 ETF'>IWM</a>) is&nbsp;<font color='red'>off 0.7%</font>. Among individual names: Amazon&nbsp;<font color='red'>-2.3%</font>, Adobe&nbsp;<font color='red'>-3.6%</font>, Salesforce.com&nbsp;<font color='red'>-4.3%</font>, Nvidia&nbsp;<font color='red'>-2.5%</font>, Netflix&nbsp;<font color='red'>-2.5%</font>, Microsoft&nbsp;<font color='red'>-1.8%</font>.</li><li>Over the last three sessions, the Nasdaq has&nbsp;<font color='red'>given up more than 4%</font>&nbsp;vs.<font color='red'> less than 2%&nbsp;</font>for the S&amp;P.</li><li>A combination of frothy valuations and breakouts to the upside across the yield curve seems behind the selling. The bond market is closed today.</li><li>What's working? Previously roughed-up defensive/interest rate plays like utilities (<a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='green'>+1%</font>) and REITs (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='green'>+1.5%</font>), (<a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a> <font color='green'>+1.5%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>, <a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>, <a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>, <a href='https://seekingalpha.com/symbol/IWM' title='iShares Russell 2000 ETF'>IWM</a>, <a href='https://seekingalpha.com/symbol/VOO' title='Vanguard S&P 500 ETF'>VOO</a>, <a href='https://seekingalpha.com/symbol/SH' title='ProShares Short S&P 500 ETF'>SH</a>, <a href='https://seekingalpha.com/symbol/SDS' title='ProShares UltraShort S&P 500 ETF'>SDS</a>, <a href='https://seekingalpha.com/symbol/TZA' title='Direxion Daily Small Cap Bear 3x Shares ETF'>TZA</a>, <a href='https://seekingalpha.com/symbol/TNA' title='Direxion Daily Small Cap Bull 3x Shares ETF'>TNA</a>, <a href='https://seekingalpha.com/symbol/IVV' title='iShares Core S&P 500 ETF'>IVV</a>, <a href='https://seekingalpha.com/symbol/SSO' title='ProShares Ultra S&P 500 ETF'>SSO</a>, <a href='https://seekingalpha.com/symbol/TQQQ' title='ProShares UltraPro QQQ ETF'>TQQQ</a>, <a href='https://seekingalpha.com/symbol/SPXU-OLD' title='ProShares UltraPro Short S&P 500 ETF'>SPXU-OLD</a>, <a href='https://seekingalpha.com/symbol/UPRO' title='ProShares UltraPro S&P 500 ETF'>UPRO</a>, <a href='https://seekingalpha.com/symbol/SPXL' title='Direxion Daily S&P 500 Bull 3x Shares ETF'>SPXL</a>, <a href='https://seekingalpha.com/symbol/RSP' title='Invesco S&P 500 Equal Weight ETF'>RSP</a>, <a href='https://seekingalpha.com/symbol/SQQQ' title='ProShares UltraPro Short QQQ ETF'>SQQQ</a>, <a href='https://seekingalpha.com/symbol/SPXS' title='Direxion Daily S&P 500 Bear 3x Shares ETF'>SPXS</a>, <a href='https://seekingalpha.com/symbol/PSQ' title='ProShares Short QQQ ETF'>PSQ</a>, <a href='https://seekingalpha.com/symbol/VFINX' title='Vanguard 500 Index Fund Inv'>VFINX</a>, <a href='https://seekingalpha.com/symbol/QID-OLD' title='ProShares UltraShort QQQ ETF'>QID-OLD</a>, <a href='https://seekingalpha.com/symbol/QLD' title='ProShares Ultra QQQ ETF'>QLD</a>, <a href='https://seekingalpha.com/symbol/UDOW' title='ProShares UltraPro Dow 30 ETF'>UDOW</a>, <a href='https://seekingalpha.com/symbol/DOG' title='ProShares Short Dow 30 ETF'>DOG</a>, <a href='https://seekingalpha.com/symbol/DXD' title='ProShares UltraShort Dow30 ETF'>DXD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3395796\" data-linked=\"Stocks continue to slump, Nasdaq down another 1.5%\" data-tweet=\"$QQQ $SPY $DIA - Stocks continue to slump, Nasdaq down another 1.5% https://seekingalpha.com/news/3395796-stocks-continue-to-slump-nasdaq-down-another-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3395796-stocks-continue-to-slump-nasdaq-down-another-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395794\" data-ts=\"1539013804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395794-ebixminus-14_9-on-auditor-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix -14.9% on auditor change</a></h4><ul><li>Ebix (NASDAQ:<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a>)&nbsp;<font color='red'>drops 14.9%</font>&nbsp;on Friday&rsquo;s <a href=\"https://seekingalpha.com/filing/4195347\" target=\"_blank\">disclosed auditor change</a> from Cherry Bekaert to T.R. Chadha &amp; Co. for the FY ending December 31.</li><li>The company intends to engage a &ldquo;Big 4&rdquo; accounting firm for FY ending in December 2019 after a selection process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395794\" data-linked=\"Ebix -14.9% on auditor change\" data-tweet=\"$EBIX - Ebix -14.9% on auditor change https://seekingalpha.com/news/3395794-ebixminus-14_9-on-auditor-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3395794-ebixminus-14_9-on-auditor-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395787\" data-ts=\"1539013024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395787-auris-up-48-ahead-of-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auris up 48% ahead of equity offering</a></h4><ul><li>Nano cap Auris Medical Holding AG (<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a> <font color='green'>+47.9%</font>) is up on almost a 7x surge in volume, adding to a rally that started shortly after the company's Type C meeting with the FDA to clarify a development and registration path for AM-111 for sudden sensorineural hearing loss. Shares have jumped&nbsp;<font color='green'>173%</font>&nbsp;since touching $0.255 on September 5.</li><li>Last week, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1601936/000095010318011593/dp96360_424b3-july.htm\" target=\"_blank\">prospectus supplement</a> for an offering of ~18M shares of common stock plus warrants (<a href=\"https://www.sec.gov/Archives/edgar/data/1601936/000114420418038529/tv498526-424b4.htm\" target=\"_blank\">original filing</a> July 16).</li></ul><div class=\"tiny-share-widget\" data-id=\"3395787\" data-linked=\"Auris up 48% ahead of equity offering\" data-tweet=\"$EARS - Auris up 48% ahead of equity offering https://seekingalpha.com/news/3395787-auris-up-48-ahead-of-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3395787-auris-up-48-ahead-of-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395785\" data-ts=\"1539011953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOT\" target=\"_blank\">TOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395785-sonatrach-to-start-offshore-drilling-total-eni-in-algeria\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonatrach to start offshore drilling with Total, Eni in Algeria</a></h4><ul>     <li>Algeria&rsquo;s Sonatrach oil and gas company Sonatrach will <a href=\"https://www.epmag.com/sonatrach-launch-offshore-drilling-total-eni-algeria-next-year-1718196\" target=\"_blank\">launch offshore drilling</a> with Total (<a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color='red'>-2.6%</font>) and Eni (<a href='https://seekingalpha.com/symbol/E' title='ENI S.p.A.'>E</a> <font color='red'>-3.6%</font>), on two sites in the eastern and western parts of the country at the start of next year, says CEO Abdelmoumene Ould Kaddour.</li><li>The comments were made as Sonatrach and TOT attended a signing ceremony for a new  jointly developed petrochemicals plant that will produce 550K metric tons/year of polypropylene.</li><li>The two companies also agree to invest $406M to increase production of the Tin Fouye Tabankort Sud gas field, with first gas expected in late 2021.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395785\" data-linked=\"Sonatrach to start offshore drilling with Total, Eni in Algeria\" data-tweet=\"$TOT $TOT $E - Sonatrach to start offshore drilling with Total, Eni in Algeria https://seekingalpha.com/news/3395785-sonatrach-to-start-offshore-drilling-total-eni-in-algeria?source=tweet\" data-url=\"https://seekingalpha.com/news/3395785-sonatrach-to-start-offshore-drilling-total-eni-in-algeria\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395780\" data-ts=\"1539011255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITG\" target=\"_blank\">ITG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395780-itg-says-index-rebalancing-hurt-september-revenue-per-share-figure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ITG says index rebalancing hurt September revenue per share figure</a></h4><ul><li>ITG (NYSE:<a href='https://seekingalpha.com/symbol/ITG' title='Investment Technology Group Inc.'>ITG</a>)&nbsp;<font color='red'>falls 1.6%</font>&nbsp;after reporting<a href=\"https://seekingalpha.com/pr/17292967-itg-releases-september-2018-u-s-trading-volumes-provides-international-trading-commission\" target=\"_blank\"> September</a> U.S. revenue per share was 8% below the average in Q2 2018, due in part to an increase in lower-rate index rebalance trading.</li><li>September U.S. trading volume of 2.7B shares edged up from 2.6B shares a year ago; August 2018 U.S. trading volume was also 2.6B.</li><li>Average daily volume was 144M shares for September, up 11% Y/Y, and up 26% from August.</li><li>There were 19 trading days in Sept. 2018, 23 trading days in Aug. 2018, and 20 trading days in Sept. 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389288-itg-trading-volume-lower-despite-increase-trading-days\" target=\"_blank\">ITG trading volume lower despite increase in trading days</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395780\" data-linked=\"ITG says index rebalancing hurt September revenue per share figure\" data-tweet=\"$ITG - ITG says index rebalancing hurt September revenue per share figure https://seekingalpha.com/news/3395780-itg-says-index-rebalancing-hurt-september-revenue-per-share-figure?source=tweet\" data-url=\"https://seekingalpha.com/news/3395780-itg-says-index-rebalancing-hurt-september-revenue-per-share-figure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395778\" data-ts=\"1539010906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMD\" target=\"_blank\">CRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395778-healthcare-top-5-gainers-losers-of-11-00-10-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='red'>-31%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NVLN' title='Novelion Therapeutics, Inc.'>NVLN</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395778\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/08/2018)\" data-tweet=\"$CRMD $CRMD $GEMP - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/08/2018) https://seekingalpha.com/news/3395778-healthcare-top-5-gainers-losers-of-11-00-10-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395778-healthcare-top-5-gainers-losers-of-11-00-10-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395775\" data-ts=\"1539010613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395775-lannett-assessing-debt-and-capital-structure-alternatives-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lannett assessing debt and capital structure alternatives; shares down 6%</a></h4><ul><li>Following its write-off of nearly $340M of goodwill and expected write-down of other assets connected to the previously announced termination of its distribution deal with Jerome Stevens Pharmaceuticals, Lannett Company (<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color='red'>-5.9%</font>) has engaged advisors to assist it in evaluating its options related to its debt and capital structure.</li><li>CEO Tim Crew says, \"We welcome the specialized expertise our advisors bring to the table, as we look to add revenues, reduce costs and more closely analyze financing options. Following the recent announcement that our distribution agreement with Jerome Stevens Pharmaceuticals, which expires on March 23, 2019, will not be renewed, we ramped up our efforts to address this eventuality and ultimately grow our business.&nbsp;I am pleased to report that we are making solid progress and our plans continue to proceed, as evidenced by the launch of five new products in our recently completed fiscal 2019 first quarter.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3384050-jerome-stevens-nixes-distribution-deal-lannett-shares-26-percent-premarket\" target=\"_blank\">Jerome Stevens nixes distribution deal with Lannett; shares down 26% premarket</a> (Aug. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395775\" data-linked=\"Lannett assessing debt and capital structure alternatives; shares down 6%\" data-tweet=\"$LCI - Lannett assessing debt and capital structure alternatives; shares down 6% https://seekingalpha.com/news/3395775-lannett-assessing-debt-and-capital-structure-alternatives-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3395775-lannett-assessing-debt-and-capital-structure-alternatives-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395774\" data-ts=\"1539010052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEIX\" target=\"_blank\">PEIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395774-pacific-ethanolplus-24-trump-set-to-unveil-pro-ethanol-measure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Ethanol +24% as Trump set to unveil pro-ethanol measure</a></h4><ul>     <li>Pacific Ethanol (<a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='green'>+23.9%</font>) skyrockets on heightened expectations that Pres. Trump will announce the <a href=\"https://www.reuters.com/article/us-trump-ethanol-iowa/trump-to-announce-pro-ethanol-measure-on-tuesday-ahead-of-iowa-trip-sources-idUSKCN1MH0NL\" target=\"_blank\">lifting of a federal ban</a> on summer sales of higher-ethanol blends of gasoline tomorrow.</li>     <li>The lifting of the summer ban on E15 gasoline reportedly will be coupled with restrictions on trading biofuel credits that underpin the program, but it is not clear whether the restrictions will be detailed or left up to the Environmental Protection Agency to decide.</li><li><a href=\"https://seekingalpha.com/news/3394646-reuters-trump-visit-iowa-next-week-announce-pro-ethanol-measure\" target=\"_blank\">Earlier</a>: Reuters:&nbsp;Trump to visit Iowa next week to announce pro-ethanol measure (Oct. 2)</li><li>Also: <a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='green'>+2.5%</font>, <a href='https://seekingalpha.com/symbol/REGI' title='Renewable Energy Group, Inc'>REGI</a> <font color='red'>-2.8%</font>, <a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> <font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/REX' title='REX American Resources Corporation'>REX</a> <font color='green'>+0.6%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/PBW' title='Invesco WilderHill Clean Energy Portfolio ETF'>PBW</a>, <a href='https://seekingalpha.com/symbol/QCLN' title='First Trust NASDAQ Clean Edge Green Energy Index ETF'>QCLN</a>, <a href='https://seekingalpha.com/symbol/FUE' title='ELEMENTS MLCX Biofuels Index Total Return ETN'>FUE</a>, <a href='https://seekingalpha.com/symbol/PUW' title='Invesco WilderHill Progressive Energy Portfolio ETF'>PUW</a>, <a href='https://seekingalpha.com/symbol/HECO' title='Huntington Ecological Strategy ETF'>HECO</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3395774\" data-linked=\"Pacific Ethanol +24% as Trump set to unveil pro-ethanol measure\" data-tweet=\"$PEIX $PEIX $GPRE - Pacific Ethanol +24% as Trump set to unveil pro-ethanol measure https://seekingalpha.com/news/3395774-pacific-ethanolplus-24-trump-set-to-unveil-pro-ethanol-measure?source=tweet\" data-url=\"https://seekingalpha.com/news/3395774-pacific-ethanolplus-24-trump-set-to-unveil-pro-ethanol-measure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395772\" data-ts=\"1539009863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395772-citron-positive-on-pyxus-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron positive on Pyxus International</a></h4><ul> <li>Shares of Pyxus International (<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a> <font color='green'>+30.8%</font>) extend on their earlier gains after Citron Research <a href=\"https://twitter.com/CitronResearch/status/1049307532496265216\" target=\"_blank\">weighs in</a> on the debate.</li> <li>\"$PYX would not short...speculative long. Real management and tight float. The stock could double from here as long as investors are Cannabis crazy,\" tweets Citron.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395760-pyxus-international-rallies-new-high\" target=\"_blank\">Pyxus International rallies to new high</a> (Oct. 8)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3395772\" data-linked=\"Citron positive on Pyxus International\" data-tweet=\"$PYX - Citron positive on Pyxus International https://seekingalpha.com/news/3395772-citron-positive-on-pyxus-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3395772-citron-positive-on-pyxus-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395768\" data-ts=\"1539009255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395768-cowen-positive-on-movado\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen positive on Movado</a></h4><ul> <li>Movado (<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+3.3%</font>) breaks higher after Cowen lifts the apparel stock to an Outperform rating from Market Perform on it expectation for growth in the wholesale channel.</li> <li>The firm sets a price target of $50 on Movado</li> <li>Shares of Movado are up 26% YTD, despite some tariff headwinds.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395768\" data-linked=\"Cowen positive on Movado\" data-tweet=\"$MOV - Cowen positive on Movado https://seekingalpha.com/news/3395768-cowen-positive-on-movado?source=tweet\" data-url=\"https://seekingalpha.com/news/3395768-cowen-positive-on-movado\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395767\" data-ts=\"1539009059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRMN\" target=\"_blank\">GRMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395767-garmin-subsidiarys-unsecured-database-exposed-customer-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Garmin subsidiary&#39;s unsecured database exposed customer data</a></h4><ul><li>        Garmin&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/GRMN' title='Garmin Ltd.'>GRMN</a>) electronic navigation chart company Navionics <a href=\"https://techcrunch.com/2018/10/08/garmin-owned-navigation-unit-exposed-thousands-of-boat-owners-data/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">had an exposed databas</a>e that contained hundreds of thousands of customer records.</li><li>               Navionics has now secured the MongoDB database, which didn&rsquo;t have a password. Hacken.io director of cyber risk research Bob Diachenko says the 19GB database included over 261K unique records including customer names, addresses, and what was likely real-time location and sensor data for the boats. &nbsp;&nbsp;</li><li>               Diachenko informed the company and Navionics closed the server.&nbsp;</li><li>               Garmin shares are&nbsp;<font color='red'>down 1.2%</font>&nbsp;to $67.81.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3395767\" data-linked=\"Garmin subsidiary&#39;s unsecured database exposed customer data\" data-tweet=\"$GRMN - Garmin subsidiary&#39;s unsecured database exposed customer data https://seekingalpha.com/news/3395767-garmin-subsidiarys-unsecured-database-exposed-customer-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3395767-garmin-subsidiarys-unsecured-database-exposed-customer-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395760\" data-ts=\"1539008268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395760-pyxus-international-rallies-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pyxus International rallies to new high</a></h4><ul> <li>Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) is <font color='green'>up 14.0%</font> and carved out a new 52-week high of $32.82 in trading earlier in the session.</li> <li>Investors appear to be latching on to the company's cannabis potential.</li> <li>Last week, <a href=\"https://seekingalpha.com/article/4209928-pyxus-international-better-growth-prospects-cheaper-valuation-tilray-canopy-growth\" target=\"_blank\">Seeking Alpha contributor PNW Value</a> broke down why it sees huge potential for Pyxus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395760\" data-linked=\"Pyxus International rallies to new high\" data-tweet=\"$PYX - Pyxus International rallies to new high https://seekingalpha.com/news/3395760-pyxus-international-rallies-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3395760-pyxus-international-rallies-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395751\" data-ts=\"1539007287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZUL\" target=\"_blank\">AZUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395751-azul-high-flyer-after-brazil-election\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Azul a high flyer after Brazil election</a></h4><ul> <li>Shares of Azul (NYSE:<a href='https://seekingalpha.com/symbol/AZUL' title='Azul'>AZUL</a>) are <font color='green'>up 10.0%</font> to fly back over $20.</li><li>The move is tied largely to the election results in Brazil.</li> <li>While Azul is now up 33% in the last 30 days, shares are still down 11% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3395751\" data-linked=\"Azul a high flyer after Brazil election\" data-tweet=\"$AZUL - Azul a high flyer after Brazil election https://seekingalpha.com/news/3395751-azul-high-flyer-after-brazil-election?source=tweet\" data-url=\"https://seekingalpha.com/news/3395751-azul-high-flyer-after-brazil-election\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395748\" data-ts=\"1539007012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMS\" target=\"_blank\">ADMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395748-adamas-pharmas-gocovri-shows-long-term-treatment-effect-in-late-stage-parkinsons-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adamas Pharma&#39;s Gocovri shows long-term treatment effect in late-stage Parkinson&#39;s study</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17293193-adamas-presents-final-results-two-year-phase-3-open-label-study-gocovri-parkinson-s-disease\" target=\"_blank\">Final results</a> from a two-year open-label Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02202551?intr=Amantadine&amp;lead=adamas&amp;phase=2&amp;rank=2\" target=\"_blank\">EASE LID 2</a>, evaluating Adamas Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ADMS' title='Adamas Pharmaceuticals, Inc.'>ADMS</a> <font color='red'>-3.1%</font>) GOCOVRI (amantadine) in patients with Parkinson's disease &#40;PD&#41; showed a sustained treatment effect. The data were presented at the International Congress of Parkinson's Disease and Movement Disorders in Hong Kong.</li><li>The treatment benefit was observed in all subgroups, including those who switched to GOCOVRI from placebo or amantadine immediate release and those with uncontrollable dyskinesia after treatment with deep brain stimulation.</li><li>Patients receiving GOCOVRI experienced a 35% reduction in dyskinesia and OFF periods from baseline at week 8 that was maintained for up to 100 weeks across all subgroups na&iuml;ve to GOCOVRI. Over 84% of patients in the treatment group either increased or maintained their levodopa dosage for up to 100 weeks while 30% increased their doses by an average of ~300 mg/day.</li><li>The FDA approved GOCOVRI in August 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395748\" data-linked=\"Adamas Pharma&#39;s Gocovri shows long-term treatment effect in late-stage Parkinson&#39;s study\" data-tweet=\"$ADMS - Adamas Pharma&#39;s Gocovri shows long-term treatment effect in late-stage Parkinson&#39;s study https://seekingalpha.com/news/3395748-adamas-pharmas-gocovri-shows-long-term-treatment-effect-in-late-stage-parkinsons-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3395748-adamas-pharmas-gocovri-shows-long-term-treatment-effect-in-late-stage-parkinsons-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395735\" data-ts=\"1539005432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395735-costs-spike-for-equinors-martin-linge-north-sea-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costs spike for Equinor&#39;s Martin Linge North Sea project</a></h4><ul>     <li>Equinor (NYSE:<a href='https://seekingalpha.com/symbol/EQNR' title='Equinor ASA'>EQNR</a>)&nbsp;<font color='red'>-2.2%</font> pre-market after Norway's latest budget <a href=\"https://www.reuters.com/article/norway-budget-equinor/update-1-equinors-martin-linge-field-costs-rise-again-start-up-delayed-idUSL8N1WO1UB\" target=\"_blank\">again revises up the estimated cost</a> of developing the Martin Linge oil and gas field in the North Sea, which state-controlled EQNR bought from Total last year, with the start-up delayed until early 2020 from H1 2019.</li>     <li>The field is now expected to cost NOK47B ($5.7B) to develop, up from the NOK41B estimated last year and 59% higher than originally planned in 2012.</li>     <li>Despite the increase, EQNR says it has cut costs for its combined developments on the Norwegian continental shelf by NOK30B crowns compared with original estimates, including a 30% cost reduction alone at its Johan Sverdrup Phase 1 development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395735\" data-linked=\"Costs spike for Equinor&#39;s Martin Linge North Sea project\" data-tweet=\"$EQNR - Costs spike for Equinor&#39;s Martin Linge North Sea project https://seekingalpha.com/news/3395735-costs-spike-for-equinors-martin-linge-north-sea-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3395735-costs-spike-for-equinors-martin-linge-north-sea-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395734\" data-ts=\"1539005361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395734-glu-mobileminus-3_5-roth-heads-to-sideline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile -3.5% as Roth heads to sideline</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) is <font color='red'>down 3.5%</font> premarket after a downgrade to Neutral at Roth Capital, which sees a dearth of near-term catalysts for the mobile gaming stock.</li>    <li>The firm trimmed its price target to $8 from $8.25, cutting implied upside to 11%.</li>    <li>After a flat entry to 2018, shares are <font color='green'>up 95.7%</font> over the past six months</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395734\" data-linked=\"Glu Mobile -3.5% as Roth heads to sideline\" data-tweet=\"$GLUU - Glu Mobile -3.5% as Roth heads to sideline https://seekingalpha.com/news/3395734-glu-mobileminus-3_5-roth-heads-to-sideline?source=tweet\" data-url=\"https://seekingalpha.com/news/3395734-glu-mobileminus-3_5-roth-heads-to-sideline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395732\" data-ts=\"1539005284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALT\" target=\"_blank\">ALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395732-altimmune-announces-25m-registered-direct-offering-shares-down-31-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altimmune announces $25M registered direct offering; shares down 31% premarket</a></h4><ul> <li>Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) has <a href=\"https://seekingalpha.com/pr/17293300-altimmune-announces-25-million-registered-direct-offering\" target=\"_blank\">entered</a> into a purchase agreement with several institutional investors for the purchase of common units and pre-funded units for a combined total of 4,629,630 units in a registered direct offering, for expected gross proceeds of ~$25M.</li>   <li>Each common unit has an offering price of $5.40 and consists of one share of common stock and a warrant to purchase one share of common stock.</li><li>Each pre-funded unit is being sold at an offering price of $5.39 and consists of a pre-funded warrant to purchase one share of common stock and a warrant to purchase one share of common stock at an exercise price of $5.40.</li><li>The public offering price of each pre-funded unit is equal to the price of each common unit, minus $0.01.</li>  <li>Net proceeds will be used for the development activities for Altimmune's product pipeline, general corporate purposes and strategic growth opportunities.</li><li>Closing date is October 10.</li><li>Shares are down&nbsp;<font color='red'>31%</font>&nbsp;premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3395732\" data-linked=\"Altimmune announces $25M registered direct offering; shares down 31% premarket\" data-tweet=\"$ALT - Altimmune announces $25M registered direct offering; shares down 31% premarket https://seekingalpha.com/news/3395732-altimmune-announces-25m-registered-direct-offering-shares-down-31-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3395732-altimmune-announces-25m-registered-direct-offering-shares-down-31-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395730\" data-ts=\"1539004972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395730-analysts-start-covering-nio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts start covering NIO</a></h4><ul> <li>Analyst coverage launches on Chinese electric vehicle stock NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a>).</li> <li>Morgan Stanley is in with an Overweight rating and price target of $8.50.</li> <li>Goldman Sachs launches coverage at Neutral and a price target of $6.56.</li> <li>Citi is also at Neutral and assigns a price target of $7.20.</li> <li>Leading the bull charge is Deutsche Bank, starting Nio off at a Buy rating with a price target of $9.50.</li> <li>Shares of NIO are <font color='red'>down 1.28%</font> in premarket trading to $6.17 vs. the post-IPO range of $5.35 to $13.80.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395730\" data-linked=\"Analysts start covering NIO\" data-tweet=\"$NIO - Analysts start covering NIO https://seekingalpha.com/news/3395730-analysts-start-covering-nio?source=tweet\" data-url=\"https://seekingalpha.com/news/3395730-analysts-start-covering-nio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395729\" data-ts=\"1539004917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395729-report-apple-and-bt-nearing-pay-tv-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Apple and BT nearing pay-TV deal</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) and British telecom BT (NYSE:<a href='https://seekingalpha.com/symbol/BT' title='BT Group plc'>BT</a>) are in talks over a partnered push into pay-TV, according to <a href=\"https://www.telegraph.co.uk/business/2018/10/07/apple-talks-bt-pay-tv-partnership/\" target=\"_blank\">The Daily Telegraph.</a> </li><li>        Sources say the early discussions involve a deal that would make BT&rsquo;s EE mobile brand a major distributor of Apple TV boxes. EE would offer the boxes, pre-loaded with apps including BT Sport, to its broadband customers.</li><li>               Apple has a similar deal in place in Switzerland with pay-TV telecom Salt.&nbsp;</li><li>               BT shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket to $15.14.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3395729\" data-linked=\"Report: Apple and BT nearing pay-TV deal\" data-tweet=\"$AAPL $AAPL $BT - Report: Apple and BT nearing pay-TV deal https://seekingalpha.com/news/3395729-report-apple-and-bt-nearing-pay-tv-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3395729-report-apple-and-bt-nearing-pay-tv-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395728\" data-ts=\"1539004696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIG\" target=\"_blank\">CIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395728-premarket-gainers-of-9-05-08-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (08/10/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color='green'>+23%</font>.</li><li>PBR-A <font color='green'>+14%</font>&nbsp;on Bolsonaro <a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a>.</li><li><a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+14%</font>&nbsp;on Bolsonaro <a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a>.</li><li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+13%</font>.</li><li><a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Aéreas Inteligentes S.A.'>GOL</a> <font color='green'>+12%</font>. on Bolsonaro <a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a> and <a href=\"https://seekingalpha.com/news/3395721-gol-pops-posting-investor-update\" target=\"_blank\">investor update</a>.</li><li><a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='green'>+11%</font>. on Bolsonaro&nbsp;<a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a></li><li><a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a> <font color='green'>+10%</font>&nbsp;on Bolsonaro&nbsp;<a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a>.</li><li><a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a> <font color='green'>+10%</font>&nbsp;as shareholder <a href=\"https://seekingalpha.com/news/3395595-kala-pharma-plus-8_7-percent-shareholder-discloses-20m-purchase\" target=\"_blank\">discloses</a> $20M purchase.</li><li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+9%</font>&nbsp;on Bolsonaro&nbsp;<a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a>.</li><li><a href='https://seekingalpha.com/symbol/SBS' title='Companhia de Saneamento Basico do Estado de Sao Paulo-SABESP'>SBS</a> <font color='green'>+9%</font>&nbsp;on Bolsonaro&nbsp;<a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">election strength</a>.</li><li><a href='https://seekingalpha.com/symbol/AZUL' title='Azul'>AZUL</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/VIV' title='Telefonica Brasil, S.A'>VIV</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395728\" data-linked=\"Premarket Gainers as of 9:05 am (08/10/2018)\" data-tweet=\"$CIG $CIG $PBR - Premarket Gainers as of 9:05 am (08/10/2018) https://seekingalpha.com/news/3395728-premarket-gainers-of-9-05-08-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395728-premarket-gainers-of-9-05-08-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395723\" data-ts=\"1539004164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395723-petrobrasplus-14-on-bolsonaro-election-strength-baml-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras +14% on Bolsonaro election strength, BAML upgrade</a></h4><ul>     <li>Petrobras (NYSE:<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a>) <font color='green'>+14.3% </font>pre-market following Jair Bolsonaro's <a href=\"https://seekingalpha.com/news/3395625-brazil-etfs-leap-bolsonaro-lead\" target=\"_blank\">strong showing</a> in Brazil's presidential election, with his 46.7% tally far exceeding the other candidates and easily beating expectations.</li>     <li>Investors have recently <a href=\"https://www.cnbc.com/2018/10/08/brazilian-shares-surge-after-far-right-presidential-candidate-wins-first-round-in-a-blowout.html\" target=\"_blank\">cheered Bolsonaro</a> because they favor his economic platform and his promises to take a tough stance against corruption.</li>     <li>Also, BofA Merrill Lynch <a href=\"https://thefly.com/thestreet/realmoney/index.php/PBRid2800814/PBR-Petrobras-upgraded-to-Buy-from-Neutral-at-BofAMerrill\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $20 price target, up from $17, saying Bolsonaro's strength reduces the perceived policy risk than had been priced into the stock.</li><li>Among other Brazilian stocks: <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='green'>+8%</font>, <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='green'>+8.3%</font>, <a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color='green'>+24.8%</font>, <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='green'>+8.8%</font>, <a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+4%</font>, <a href='https://seekingalpha.com/symbol/SBS' title='Companhia de Saneamento Basico do Estado de Sao Paulo-SABESP'>SBS</a> <font color='green'>+8.4%</font>, <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+9.1%</font>, <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='green'>+10.6%</font>, <a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a> <font color='green'>+10.4%</font>, <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+6.5%</font>, <a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Aéreas Inteligentes S.A.'>GOL</a> <font color='green'>+13.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a>, <a href='https://seekingalpha.com/symbol/BRZU' title='Direxion Daily Brazil Bull 3x Shares ETF'>BRZU</a>, <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a>, <a href='https://seekingalpha.com/symbol/EWZS' title='iShares MSCI Brazil Small-Cap ETF'>EWZS</a>, <a href='https://seekingalpha.com/symbol/BZQ' title='ProShares UltraShort MSCI Brazil Capped ETF'>BZQ</a>, <a href='https://seekingalpha.com/symbol/BRAQ' title='Global X Brazil Consumer ETF'>BRAQ</a>, <a href='https://seekingalpha.com/symbol/UBR' title='ProShares Ultra MSCI Brazil Capped ETF'>UBR</a>, <a href='https://seekingalpha.com/symbol/BRAZ' title='Global X Brazil Mid-Cap ETF'>BRAZ</a>, <a href='https://seekingalpha.com/symbol/DBBR' title='Deutsche X-trackers MSCI Brazil Hedged Equity ETF'>DBBR</a>, <a href='https://seekingalpha.com/symbol/FBZ' title='First Trust Brazil AlphaDEX ETF'>FBZ</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3395723\" data-linked=\"Petrobras +14% on Bolsonaro election strength, BAML upgrade\" data-tweet=\"$PBR $PBR $VALE - Petrobras +14% on Bolsonaro election strength, BAML upgrade https://seekingalpha.com/news/3395723-petrobrasplus-14-on-bolsonaro-election-strength-baml-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3395723-petrobrasplus-14-on-bolsonaro-election-strength-baml-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395722\" data-ts=\"1539004103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALT\" target=\"_blank\">ALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395722-premarket-losers-of-9-05-10-8-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (10/8/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='red'>-32%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17293300-altimmune-announces-25-million-registered-direct-offering\" target=\"_blank\">announcing</a> $25M registered direct offering.</li><li><a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395722\" data-linked=\"Premarket Losers as of 9:05 am (10/8/2018)\" data-tweet=\"$ALT $ALT $VTVT - Premarket Losers as of 9:05 am (10/8/2018) https://seekingalpha.com/news/3395722-premarket-losers-of-9-05-10-8-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3395722-premarket-losers-of-9-05-10-8-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395721\" data-ts=\"1539003889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOL\" target=\"_blank\">GOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395721-gol-pops-after-posting-investor-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GOL pops after posting investor update</a></h4><ul> <li>GOL Linhas (NYSE:<a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Aéreas Inteligentes S.A.'>GOL</a>) rallies in premarket action after posting an investor update.</li><li>The airline company says it expects a Q3 operating margin of 5.0% to 5.5% vs. 12.2% a year ago due largely to F/X swings and elevated jet fuel prices.</li><li>Passenger unit revenue is expected to be up 4.5% to 5.0%.</li><li>Non-fuel costs are seen rising 2.5%.</li><li>GOL also forecasts an EBITDA margin of 11.0% to 11.5%.</li><li>GOL  <font color='green'>+13.73%</font> premarket to  $7.29.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17293232-gol-announces-investor-update\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3395721\" data-linked=\"GOL pops after posting investor update\" data-tweet=\"$GOL - GOL pops after posting investor update https://seekingalpha.com/news/3395721-gol-pops-after-posting-investor-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3395721-gol-pops-after-posting-investor-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395713\" data-ts=\"1539003196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOVN\" target=\"_blank\">NOVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395713-novan-expands-nitric-oxide-dermatology-business-partnership-sato-in-japan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novan expands nitric oxide dermatology business partnership with Sato in Japan</a></h4><ul> <li>Novan&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a>) has <a href=\"https://seekingalpha.com/pr/17293137-novan-expands-nitric-oxide-dermatology-business-partnership-sato-japan\" target=\"_blank\">expanded</a> its partnership with Sato Pharmaceutical Co., to include Novan&rsquo;s topical nitric oxide-releasing product candidate SB206 for the treatment of viral skin infections including warts and molluscum contagiosum.</li>     <li>The initial licensing agreement executed in January 2017 focused on the commercialization of SB204 for the treatment of acne vulgaris in&nbsp;Japan.</li><li>This amended agreement provides Sato with the exclusive rights to also develop and commercialize Novan&rsquo;s SB206 and related dosage forms for the treatment of viral skin infections in Japan.</li><li>Under the terms of the amendment, Novan will receive an upfront payment of 1.25B JPY (~$11M) to be paid in installments over the next 12 months.</li><li>As part of the revised agreement, the parties adjusted potential future development and regulatory milestone payments, added additional sales-based milestone payments and adopted a tiered royalty structure on net sales of SB204 and SB206 in Japan.</li>    <li>NOVN shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3395713\" data-linked=\"Novan expands nitric oxide dermatology business partnership with Sato in Japan\" data-tweet=\"$NOVN - Novan expands nitric oxide dermatology business partnership with Sato in Japan https://seekingalpha.com/news/3395713-novan-expands-nitric-oxide-dermatology-business-partnership-sato-in-japan?source=tweet\" data-url=\"https://seekingalpha.com/news/3395713-novan-expands-nitric-oxide-dermatology-business-partnership-sato-in-japan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395712\" data-ts=\"1539003080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMAT\" target=\"_blank\">LMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395712-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>LeMaitre Vascular (NASDAQ:<a href='https://seekingalpha.com/symbol/LMAT' title='LeMaitre Vascular, Inc.'>LMAT</a>) upgraded to Outperform with a $34 (19% upside) price target at Barrington Research citing undervaluation. Shares up&nbsp;<font color='green'>3%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395712\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$LMAT - Premarket analyst action - healthcare https://seekingalpha.com/news/3395712-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3395712-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395711\" data-ts=\"1539003043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONDK\" target=\"_blank\">ONDK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395711-ondeckplus-3_9-premarket-on-btig-upgrade-shares-reasonably-valued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OnDeck +3.9% premarket on BTIG upgrade as shares `more reasonably valued&#39;</a></h4><ul><li>OnDeck Capital (NYSE:<a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a>)<font color='green'> +3.9%</font>&nbsp;in premarket trading as BTIG analyst Mark Palmer<a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=beejfk-b\" target=\"_blank\"> upgrades </a>the stock to neutral from sell, saying its shares are now \"more reasonably valued\" after mid-August sell-off.</li><li>After the 21% stock decline in mid-August, ONDK trades at about 13.9x and 11.5x it FY19E and FY20E adjusted EPS, respectively. This is close to the level at which the stock traded before it rose in early August.</li><li>Palmer sees ONDK trading within +/-15% from current levels over next 12 months; BTIG doesn't assign price targets to neutral-rated stocks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3382435-deck-slumps-premarket-btig-downgrades-sell\" target=\"_blank\">On Deck slumps premarket as BTIG downgrades to sell</a> (Aug. 14)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3379347-ondeck-jumps-18-percent-q2-beat-raise\" target=\"_blank\">OnDeck jumps 18% after Q2 beat and raise</a> (Aug. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395711\" data-linked=\"OnDeck +3.9% premarket on BTIG upgrade as shares `more reasonably valued&#39;\" data-tweet=\"$ONDK - OnDeck +3.9% premarket on BTIG upgrade as shares `more reasonably valued&#39; https://seekingalpha.com/news/3395711-ondeckplus-3_9-premarket-on-btig-upgrade-shares-reasonably-valued?source=tweet\" data-url=\"https://seekingalpha.com/news/3395711-ondeckplus-3_9-premarket-on-btig-upgrade-shares-reasonably-valued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395708\" data-ts=\"1539002625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395708-jpmorgan-sees-volatility-in-dynavax-on-release-of-sdminus-101-data-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan sees volatility in Dynavax on release of SD-101 data; shares up 2% premarket</a></h4><ul><li>In a note, JPMorgan's Anupam Rama says Dynavax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) could jump 50% or drop 10% when data are released from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02521870?intr=SD-101&amp;lead=dynavax&amp;rank=4\" target=\"_blank\">Phase 1b/2 clinical trial</a> evaluating SD-101 + Merck's Keytruda (pembrolizumab) in patients with metastatic melanoma or recurrent/metastatic head and neck squamous cell carcinoma. Updated results will be presented at ESMO in Munich October 19-23.</li><li>Mr. Rama believes shares will rally if the overall response rate &#40;ORR&#41; is over 70%, but could fall if the ORR is below 60%. Interim data presented as ASCO in May showed an ORR of 60%.</li><li>Investors need some good news. Shares are down&nbsp;<font color='red'>43%</font>&nbsp;this year.</li><li>#ESMO</li><li>Previously: <a href=\"https://seekingalpha.com/news/3357644-dynavax-13-percent-sdminus-101-keytruda-melanoma-data\" target=\"_blank\">Dynavax down 13% on SD-101/Keytruda melanoma data</a> (May 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395708\" data-linked=\"JPMorgan sees volatility in Dynavax on release of SD-101 data; shares up 2% premarket\" data-tweet=\"$DVAX - JPMorgan sees volatility in Dynavax on release of SD-101 data; shares up 2% premarket https://seekingalpha.com/news/3395708-jpmorgan-sees-volatility-in-dynavax-on-release-of-sdminus-101-data-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3395708-jpmorgan-sees-volatility-in-dynavax-on-release-of-sdminus-101-data-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395707\" data-ts=\"1539002559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NHYDY\" target=\"_blank\">NHYDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395707-aluminum-sinks-norsk-hydro-eyes-brazil-refinery-reopen-half-capacity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aluminum sinks as Norsk Hydro eyes Brazil refinery reopen at half capacity</a></h4><ul>     <li>Aluminum prices plunge after Norsk Hydro (<a href='https://seekingalpha.com/symbol/NHYDY' title='Norsk Hydro ASA ADR'>OTCQX:NHYDY</a>) says it was granted a permit in Brazil to use new technology to extend the life of a disposal area for its Alunorte alumina refinery, which should lead to the <a href=\"https://www.reuters.com/article/us-norsk-hydro-brazil/hydro-gets-key-tech-permit-for-brazil-plant-plans-to-restart-operations-idUSKCN1MG0CU\" target=\"_blank\">restart of operations at 50%</a>.</li>     <li>The decision comes just days after Norsk Hydro said it would <a href=\"https://seekingalpha.com/news/3394721-alcoa-aluminum-surge-worlds-largest-alumina-factory-stops-production\" target=\"_blank\">stop production</a> and layoff 4,700 people at Alunorte, which has been operating at half capacity since March due to an environmental dispute.</li>     <li>Alunorte made 6.4M metric tons of alumina in 2017, ~10% of global production outside China and enough to make 3M metric tons of aluminum.</li><li><a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-3.2%</font>, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+7%</font> pre-market; <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>, <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a>, <a href='https://seekingalpha.com/symbol/KALU' title='Kaiser Aluminum Corporation'>KALU</a> and <a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Ltd'>ACH</a> also are on watch.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a>, <a href='https://seekingalpha.com/symbol/JJUB' title='iPath Series B Bloomberg Aluminum Subindex Total Return ETN'>JJUB</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3395707\" data-linked=\"Aluminum sinks as Norsk Hydro eyes Brazil refinery reopen at half capacity\" data-tweet=\"$NHYDY $NHYDY $AA - Aluminum sinks as Norsk Hydro eyes Brazil refinery reopen at half capacity https://seekingalpha.com/news/3395707-aluminum-sinks-norsk-hydro-eyes-brazil-refinery-reopen-half-capacity?source=tweet\" data-url=\"https://seekingalpha.com/news/3395707-aluminum-sinks-norsk-hydro-eyes-brazil-refinery-reopen-half-capacity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395700\" data-ts=\"1539002129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395700-china-lending-surges-89-on-pact-lixin-for-possible-restructuring-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Lending surges 89% on pact with Lixin for possible restructuring, M&amp;A</a></h4><ul><li>China Lending Corp. (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>)&nbsp;<font color='green'>shoots up 85%</font>&nbsp;in premarket on thin trading after reporting a pact through which Zhejiang Lixin Holding will make \"full use of its related resources in helping China Lending revitalize its business through possible reorganization and restructuring as well as assisting the company to explore potential merger and acquisition opportunities.\"</li><li>The partnership aims to help CLDC upgrade its product portfolio to include multiple ways of micro financing currently in market demand, increase its market share in the segmented niches of supply-chain financing, and expand its business to eastern regions of China.</li><li>In return, Lixin hopes to access China's western regional markets.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3382210-china-lending-reports-1h-results\" target=\"_blank\">China Lending reports 1H results</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3395700\" data-linked=\"China Lending surges 89% on pact with Lixin for possible restructuring, M&amp;A\" data-tweet=\"$CLDC - China Lending surges 89% on pact with Lixin for possible restructuring, M&amp;A https://seekingalpha.com/news/3395700-china-lending-surges-89-on-pact-lixin-for-possible-restructuring-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3395700-china-lending-surges-89-on-pact-lixin-for-possible-restructuring-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395699\" data-ts=\"1539002049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395699-viking-therapeutics-announces-positive-data-from-in-vivo-study-of-vk2809\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viking Therapeutics announces positive data from in vivo study of VK2809</a></h4><ul><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a>) <a href=\"https://seekingalpha.com/pr/17293010-viking-therapeutics-announces-data-vivo-study-vk2809-presented-oral-plenary-session-88th\" target=\"_blank\">presents</a> positive data from a study of VK2809 in an in vivo model of glycogen storage disease type Ia (GSD Ia) at the 88<sup>th</sup> Annual Meeting of the American Thyroid Association in Washington, D.C.</li><li>The results demonstrated that treatment with VK2809 led to an overall improvement in liver health highlighted by restoration of autophagy, reduction in steatosis, and improvements in inflammation and liver size. The study investigators concluded that these histological improvements are potentially relevant to non-alcoholic fatty liver disease, including non-alcoholic steatohepatitis, due to certain similarities between those conditions and GSD Ia.</li>   <li>Importantly, this study also demonstrated indications of reduced inflammatory signalling following treatment with VK2809.</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395699\" data-linked=\"Viking Therapeutics announces positive data from in vivo study of VK2809\" data-tweet=\"$VKTX - Viking Therapeutics announces positive data from in vivo study of VK2809 https://seekingalpha.com/news/3395699-viking-therapeutics-announces-positive-data-from-in-vivo-study-of-vk2809?source=tweet\" data-url=\"https://seekingalpha.com/news/3395699-viking-therapeutics-announces-positive-data-from-in-vivo-study-of-vk2809\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395693\" data-ts=\"1539001584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395693-inovio-successfully-develops-first-dmab-checkpoint-inhibitor-and-demonstrates-tumor-shrinkage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio successfully develops first dMAb checkpoint inhibitor and demonstrates tumor shrinkage in preclinical studies</a></h4><ul><li>Inovio Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) <a href=\"https://seekingalpha.com/pr/17293119-inovio-successfully-develops-first-dna-encoded-monoclonal-antibody-dmab-checkpoint-inhibitor\" target=\"_blank\">announces</a> the successful animal testing of DNA-encoded monoclonal antibodies (dMAb) targeting the immune checkpoint molecule CTLA-4 as published in Cancer Research.</li><li>The preclinical study demonstrated that highly optimized dMAbs targeting mouse CTLA-4 protein can be robustly expressed in vivo, and shrank tumors in mice. More importantly, Inovio&rsquo;s dMAb constructs for anti-human CTLA-4 antibodies ipilimumab (YERVOY) and tremelimumab, achieved high expression levels in mice (~85&micro;g/ml and 58&micro;g/ml, respectively).</li><li>These dMAbs exhibited long-term expression with maintenance of serum levels &gt;15&micro;g/ml for over a year.</li><li>This research publication is the first to report on the use of Inovio dMAb technology to develop novel monoclonal antibody-based therapies targeting checkpoint inhibitors.</li>             <li>The Company plans on advancing the first clinical dMAb candidate into the first-in-human study in 2019.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3395693\" data-linked=\"Inovio successfully develops first dMAb checkpoint inhibitor and demonstrates tumor shrinkage in preclinical studies\" data-tweet=\"$INO - Inovio successfully develops first dMAb checkpoint inhibitor and demonstrates tumor shrinkage in preclinical studies https://seekingalpha.com/news/3395693-inovio-successfully-develops-first-dmab-checkpoint-inhibitor-and-demonstrates-tumor-shrinkage?source=tweet\" data-url=\"https://seekingalpha.com/news/3395693-inovio-successfully-develops-first-dmab-checkpoint-inhibitor-and-demonstrates-tumor-shrinkage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395689\" data-ts=\"1539000761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GXYEF\" target=\"_blank\">GXYEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395689-macau-stocks-after-morgan-stanley-reels-in-ggr-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau stocks after Morgan Stanley reels in GGR forecast</a></h4><ul> <li>Morgan Stanley lowers its <a href=\"https://www.bloomberg.com/news/articles/2018-10-08/lady-luck-not-likely-to-shine-on-macau-after-robust-golden-week\" target=\"_blank\">forecast</a> on 2018 Macau gaming revenue growth to +13% from +16% and drops its GGR estimate for next year to +5% from +12%.</li> <li>The dour outlook from MS is taking some of the punch out of early positive signs on Golden Week traffic (Chinese tourist arrivals +14% Y/Y).</li> <li>Macau stocks sank in Hong Kong today, led by a <font color='red'>6.6% decline</font> in Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>) and <font color='red'>5.4% drop</font> for SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>, <a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>). In premarket trading in the U.S., Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) is <font color='red'>down 2.2%</font> and Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) is <font color='red'>off 1.60%</font>. Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) is showing a <font color='red'>1.4% loss</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395689\" data-linked=\"Macau stocks after Morgan Stanley reels in GGR forecast\" data-tweet=\"$GXYEF $GXYEF $SJMHF - Macau stocks after Morgan Stanley reels in GGR forecast https://seekingalpha.com/news/3395689-macau-stocks-after-morgan-stanley-reels-in-ggr-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3395689-macau-stocks-after-morgan-stanley-reels-in-ggr-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395650\" data-ts=\"1539000443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395650-tetraphase-pharmaceuticals-announces-positive-data-from-clinical-trials-of-xerava-and-tpminus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetraphase Pharmaceuticals announces positive data from clinical trials of XERAVA and TP-6076 at IDWeek 2018</a></h4><ul> <li>Tetraphase Pharmaceuticals&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a>) <a href=\"https://seekingalpha.com/pr/17292947-tetraphase-pharmaceuticals-announces-presentation-positive-data-phase-3-trials-xerava\" target=\"_blank\">announces</a> data from a pooled analysis of two Phase 3 studies of XERAVA in complicated intra-abdominal infection (cIAI) and a Phase 1 multiple-ascending dose study for TP-6076. These data were presented at the Infectious Disease Society of America&rsquo;s Infectious Disease Week (IDWeek) 2018, held October 3-7 in San Francisco.</li>            <li>Among the 415 patients treated with XERAVA and 431 patients treated with comparators, 39 and 40 patients, respectively, had concurrent bacteremia. For patients with concurrent bacteremia caused by Gram-positive bacteria or anaerobes, the microbiological eradication was 100% for those treated with XERAVA as well as for those treated with comparators. Patients with bacteremia due to Gram-negative pathogens, including Escherichia coli, achieved 93% microbiological eradication when treated with XERAVA or a comparator.</li><li>TP-6076 demonstrated favorable pharmacokinetic and safety profile in Phase 1 trial, supporting advancement into&nbsp;a bronchopulmonary disposition&nbsp;study in Q1 2019.</li><li>Shares are up&nbsp;<font color='green'>7%</font>&nbsp;premarket.</li>                  </ul><div class=\"tiny-share-widget\" data-id=\"3395650\" data-linked=\"Tetraphase Pharmaceuticals announces positive data from clinical trials of XERAVA and TP-6076 at IDWeek 2018\" data-tweet=\"$TTPH - Tetraphase Pharmaceuticals announces positive data from clinical trials of XERAVA and TP-6076 at IDWeek 2018 https://seekingalpha.com/news/3395650-tetraphase-pharmaceuticals-announces-positive-data-from-clinical-trials-of-xerava-and-tpminus?source=tweet\" data-url=\"https://seekingalpha.com/news/3395650-tetraphase-pharmaceuticals-announces-positive-data-from-clinical-trials-of-xerava-and-tpminus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395678\" data-ts=\"1538999701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395678-piper-jaffray-steps-to-side-on-irobot-sharesminus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray steps to side on iRobot; shares -2%</a></h4><ul><li>        Piper Jaffray downgrades iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) from Overweight to Neutral with a $90 price target, a 15% downside to Friday&rsquo;s close.</li><li>               Analyst Troy Jensen cites valuation amid the recent outperformance and potential downside risk from trade tariffs.&nbsp;</li><li>               Source: StreetAccount.&nbsp;</li><li>               IRBT shares are<font color='red'> down 2%</font>&nbsp;premarket to $103.90.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3395678\" data-linked=\"Piper Jaffray steps to side on iRobot; shares -2%\" data-tweet=\"$IRBT - Piper Jaffray steps to side on iRobot; shares -2% https://seekingalpha.com/news/3395678-piper-jaffray-steps-to-side-on-irobot-sharesminus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3395678-piper-jaffray-steps-to-side-on-irobot-sharesminus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395676\" data-ts=\"1538999358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395676-bausch-healths-bryhali-lotion-receives-tentative-fda-approval-for-plaque-psoriasis-in-adults\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bausch Health&#39;s BRYHALI Lotion receives tentative FDA approval for plaque psoriasis in adults</a></h4><ul> <li>Bausch Health Companies (NYSE:<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a>) and its dermatology business, Ortho Dermatologics, <a href=\"https://seekingalpha.com/pr/17293002-bausch-healths-bryhali-halobetasol-propionate-lotion-0_01-percent-receives-tentative-fda\" target=\"_blank\">announces</a> that the FDA has provided tentative approval of the New Drug Application for BRYHALI (halobetasol propionate) Lotion, 0.01%, for the topical treatment of plaque psoriasis in adult patients.</li>   <li>BRYHALI Lotion is a new potent to superpotent corticosteroid that contains 0.01% halobetasol propionate in a novel vehicle lotion.</li><li>The final FDA approval is pending the expiration of exclusivity for a related product. The company plans to launch BRYHALI Lotion in November 2018.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3395676\" data-linked=\"Bausch Health&#39;s BRYHALI Lotion receives tentative FDA approval for plaque psoriasis in adults\" data-tweet=\"$BHC - Bausch Health&#39;s BRYHALI Lotion receives tentative FDA approval for plaque psoriasis in adults https://seekingalpha.com/news/3395676-bausch-healths-bryhali-lotion-receives-tentative-fda-approval-for-plaque-psoriasis-in-adults?source=tweet\" data-url=\"https://seekingalpha.com/news/3395676-bausch-healths-bryhali-lotion-receives-tentative-fda-approval-for-plaque-psoriasis-in-adults\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395675\" data-ts=\"1538999310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395675-reuters-large-p-e-consortium-forms-in-bid-to-acquire-arconic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Large P-E consortium forms in bid to acquire Arconic</a></h4><ul>     <li>Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>)&nbsp;<font color='green'>+4.2%</font> pre-market after Reuters reports that Blackstone (NYSE:<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a>), Carlyle (NASDAQ:<a href='https://seekingalpha.com/symbol/CG' title='The Carlyle Group'>CG</a>), Onex (<a href='https://seekingalpha.com/symbol/ONEXF' title='Onex Corporation'>OTCPK:ONEXF</a>) and Canada Pension Plan Investment Board have <a href=\"https://www.reuters.com/article/us-arconic-m-a-privateequity-exclusive/exclusive-large-private-equity-consortium-forms-for-arconic-bid-sources-idUSKCN1MH0WQ\" target=\"_blank\">joined forces in a bid to buy</a> the maker of aluminum products, which will decide later this month whether to agree to a sale.</li>     <li>The private equity consortium faces competition from other buyout firms, including Apollo Global Management (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>), according to the report.</li>     <li>Activist hedge fund Elliott Management, which won board representation at ARNC last year following a proxy contest, reportedly has been pushing the company to explore a sale.</li><li><a href=\"https://seekingalpha.com/news/3385667-arconic-reportedly-talks-sell-reuters\" target=\"_blank\">Earlier</a>: Arconic reportedly in talks to sell itself:&nbsp;Reuters (Aug. 24)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395675\" data-linked=\"Reuters: Large P-E consortium forms in bid to acquire Arconic\" data-tweet=\"$ARNC $ARNC $BX - Reuters: Large P-E consortium forms in bid to acquire Arconic https://seekingalpha.com/news/3395675-reuters-large-p-e-consortium-forms-in-bid-to-acquire-arconic?source=tweet\" data-url=\"https://seekingalpha.com/news/3395675-reuters-large-p-e-consortium-forms-in-bid-to-acquire-arconic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395671\" data-ts=\"1538998973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGIX\" target=\"_blank\">CGIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395671-cancer-genetics-up-16-on-collaborating-cellaria-for-precision-medicine-tools\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cancer Genetics up 16% on collaborating with Cellaria for precision medicine tools</a></h4><ul><li>Cancer Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>) <a href=\"https://seekingalpha.com/pr/17292994-cancer-genetics-cellaria-partner-precision-medicine-tools\" target=\"_blank\">collaborates</a> with Cellaria, LLC to develop extensive precision medicine tools and platform technologies to support the development of new cancer therapeutics.</li>   <li>This collaboration came about as part of Cancer Genetic's 2018 transformation strategy.</li><li>Financial terms are not disclosed.</li><li>CGIX shares are up&nbsp;<font color='green'>16%</font>&nbsp;premarket</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3395671\" data-linked=\"Cancer Genetics up 16% on collaborating with Cellaria for precision medicine tools\" data-tweet=\"$CGIX - Cancer Genetics up 16% on collaborating with Cellaria for precision medicine tools https://seekingalpha.com/news/3395671-cancer-genetics-up-16-on-collaborating-cellaria-for-precision-medicine-tools?source=tweet\" data-url=\"https://seekingalpha.com/news/3395671-cancer-genetics-up-16-on-collaborating-cellaria-for-precision-medicine-tools\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395670\" data-ts=\"1538998931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395670-barnes-nobleplus-3-on-m-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble +3% on M&amp;A hopes</a></h4><ul> <li>Barnes &amp; Noble (NYSE:<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a>) is <font color='green'>up 3.0%</font> in premarket trading to $7.16 as investors keep an eye on the bidding contest for the retailer.</li> <li>Barron's <a href=\"https://www.barrons.com/articles/why-barnes-noble-has-untapped-potential-1538784000\" target=\"_blank\">notes</a> that a strategic buyer could pay in the double-digit range for B&amp;N, pointing out that it is only valued at 4X EBITDA vs. 6X to 10X for most retailers.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3395070-kicking-tires-barnes-and-noble\" target=\"_blank\">Who's kicking the tires at Barnes &amp; Noble?</a> (Oct. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395670\" data-linked=\"Barnes &amp; Noble +3% on M&amp;A hopes\" data-tweet=\"$BKS - Barnes &amp; Noble +3% on M&amp;A hopes https://seekingalpha.com/news/3395670-barnes-nobleplus-3-on-m-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3395670-barnes-nobleplus-3-on-m-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395654\" data-ts=\"1538996873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESV\" target=\"_blank\">ESV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395654-offshore-drillers-ensco-rowan-to-merge-in-all-stock-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Offshore drillers Ensco, Rowan to merge in all-stock deal</a></h4><ul>     <li>Ensco (NYSE:<a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a>) and Rowan (NYSE:<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a>) <a href=\"https://seekingalpha.com/pr/17292959-ensco-plc-rowan-companies-plc-agree-combine-creating-industry-leading-offshore-driller\" target=\"_blank\">agree to merge</a> in an all-stock deal to \"create an industry leader in offshore drilling across all water depths\" and the broadest geographic presence of any offshore driller.</li>     <li>Under the deal terms, RDC shareholders will       receive 2.215 ESV shares for each RDC share; upon closing, ESV and RDC shareholders will own 60.5% and 39.5%, respectively, of the outstanding shares of the combined company.</li>     <li>The combined company expects to realize ~$150M in annual pre-tax expense synergies and to be accretive to cash flow per share in 2020.</li>     <li>Rowan President and CEO Tom Burke will become President and CEO of the combined company, and Ensco President and CEO Carl Trowell will become Chairman.</li>     <li>RDC&nbsp;<font color='green'>+2.8%</font>, ESV <font color='green'>+1.2%</font> pre-market.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3395654\" data-linked=\"Offshore drillers Ensco, Rowan to merge in all-stock deal\" data-tweet=\"$ESV $VAL $RDC - Offshore drillers Ensco, Rowan to merge in all-stock deal https://seekingalpha.com/news/3395654-offshore-drillers-ensco-rowan-to-merge-in-all-stock-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3395654-offshore-drillers-ensco-rowan-to-merge-in-all-stock-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>130&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3395653\" data-ts=\"1538996554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3395653-ge-sharesplus-2-after-latest-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE shares +2% after latest upgrade</a></h4><ul><li>General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) <font color='green'>+2%</font> premarket after Barclays <a href=\"https://www.cnbc.com/2018/10/08/ge-shares-jump-after-barclays-upgrades-to-buy.html?__source=yahoo%7Cfinance%7Cheadline%7Cstory%7C&amp;par=yahoo&amp;yptr=yahoo\" target=\"_blank\">upgraded</a> the stock to Overweight from Equalweight, saying the new CEO will lead a turnaround and most of the possible bad news is already priced into the stock.</li><li>\"Even the most hardened skeptic might want to re-consider following the CEO change,\" wrote analyst Julian Mitchell. \"While we do not yet know the magnitude of the 2018 guidance cuts, talking to investors we believe they are broadly braced for EPS of $0.75 for 2018, FCF (free cash flow) of $0.50, and a dividend cut of 75% plus.\"</li><li>He also laid out a \"blue sky\" scenario that takes the stock to more than $20 a share if Culp can aggressively improve profitability.</li><li>GE <font color='green'>jumped more than 16%</font> last week, its best weekly run in nine years, after ousting CEO John Flannery and naming former Danaher CEO Larry Culp to replace him.</li></ul><div class=\"tiny-share-widget\" data-id=\"3395653\" data-linked=\"GE shares +2% after latest upgrade\" data-tweet=\"$GE - GE shares +2% after latest upgrade https://seekingalpha.com/news/3395653-ge-sharesplus-2-after-latest-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3395653-ge-sharesplus-2-after-latest-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":66,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}